Jun Tanaka

601 total citations
50 papers, 444 citations indexed

About

Jun Tanaka is a scholar working on Molecular Biology, Computer Networks and Communications and Information Systems. According to data from OpenAlex, Jun Tanaka has authored 50 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Computer Networks and Communications and 6 papers in Information Systems. Recurrent topics in Jun Tanaka's work include Metabolism, Diabetes, and Cancer (7 papers), Cloud Computing and Resource Management (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Jun Tanaka is often cited by papers focused on Metabolism, Diabetes, and Cancer (7 papers), Cloud Computing and Resource Management (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Jun Tanaka collaborates with scholars based in Japan, Germany and United States. Jun Tanaka's co-authors include Anthony B. Pinkerton, Stephen J. Gardell, Eduard Sergienko, E. Hampton Sessions, Emmanuel S. Burgos, Jeffrey A. Culver, Jennifer S. Hirschi, Steven R. Smith, Shoichi Kanda and Jeanne K. Brooks and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and International Journal of Molecular Sciences.

In The Last Decade

Jun Tanaka

43 papers receiving 434 citations

Peers

Countries citing papers authored by Jun Tanaka

Since Specialization

Citations

This map shows the geographic impact of Jun Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Tanaka more than expected).

Fields of papers citing papers by Jun Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Tanaka. The network helps show where Jun Tanaka may publish in the future.

Co-authorship network of co-authors of Jun Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Tanaka. A scholar is included among the top collaborators of Jun Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Tanaka. Jun Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-human TLR7 antibody for therapeutic intervention in systemic lupus erythematosus 2025 ·International Immunology ·Ryutaro Fukui, Yusuke Murakami, Atsuo Kanno, Yuji Motoi, (unknown), (unknown), (unknown), (unknown), Takashi Kagari, (unknown), Michinori Kadokura, Takashi Isobe, Yoshiaki Tomimori, Jun Tanaka, Giorgio Senaldi, Toshiyuki Shimizu, Kensuke Miyake	1
2	Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan 2025 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), T. Sasaki, Takayuki Katsube, Seiichi Hayato, (unknown), Jun Tanaka, (unknown), (unknown), Atsushi Kitamura, (unknown), Hideki Suganami, (unknown), Chihiro Hasegawa	1
3	Characterization of two rice GH18 chitinases belonging to family 8 of plant pathogenesis-related proteins 2022 ·Plant Science ·Jun Tanaka, (unknown), (unknown), Tamo Fukamizo, Tomoyuki Numata, Takayuki Ohnuma	8
4	Field trial for the new-tech revegetation method harmonized with deer using <i>Zoysia japonica</i> Steud and common method 2022 ·Journal of the Japanese Society of Revegetation Technology ·Jun Tanaka, (unknown), (unknown), Hideaki Inaba	0
5	Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators 2021 ·Bioorganic & Medicinal Chemistry Letters ·Anthony B. Pinkerton, E. Hampton Sessions, Paul Hershberger, Patrick Maloney, Satyamaheshwar Peddibhotla, (unknown), Eduard Sergienko, Chen-Ting Ma, Layton H. Smith, Michael R. Jackson, Jun Tanaka, Takashi Tsuji, (unknown), (unknown), Tsuyoshi Nakamura, Stephen J. Gardell	15
6	Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition 2021 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Takashi Tsuji, Yoshitaka Sogawa, Koji Terayama, Mika Yokoyama, Jun Tanaka, Daigo Asano, Ken Sakurai, Eduard Sergienko, E. Hampton Sessions, Stephen J. Gardell, Anthony B. Pinkerton, Tsuyoshi Nakamura	9
7	Boosting NAD+ with a small molecule that activates NAMPT 2019 ·Nature Communications ·Stephen J. Gardell, (unknown), (unknown), (unknown), E. Hampton Sessions, (unknown), Nidhi Kapoor, Jeanne K. Brooks, Jeffrey A. Culver, Chris Petucci, (unknown), (unknown), Jun Tanaka, Emmanuel S. Burgos, Jennifer S. Hirschi, Steven R. Smith, Eduard Sergienko, Anthony B. Pinkerton	121
8	Discovery of novel pyridazine derivatives as glucose transporter type 4 (GLUT4) translocation activators 2019 ·Bioorganic & Medicinal Chemistry Letters ·Takashi Tsuji, Mitsuhiro Yamaguchi, (unknown), (unknown), Masahiro Konishi, Koji Terayama, Jun Tanaka, Motoko Saito, Yoshiyuki Kobayashi	20
9	Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Kunihiko Fujii, (unknown), Kousei Shimada, Yoshiyuki Onishi, Yumi Matsui, (unknown), Masanori Kuroha, (unknown), Kazushi Araki, Jun Ohsumi, (unknown), Nobuaki Watanabe, Hideki Yamamoto, Kazunori Fujimoto, (unknown), Makoto Mori, Jun Tanaka	7
10	Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Kunihiko Fujii, (unknown), Kousei Shimada, Yoshiyuki Onishi, Yumi Matsui, (unknown), Masanori Kuroha, (unknown), Kazushi Araki, Jun Ohsumi, (unknown), Nobuaki Watanabe, Hideki Yamamoto, Kazunori Fujimoto, (unknown), Makoto Mori, Jun Tanaka	11
11	Mode of action and specificity of a chitinase from unicellular microalgae, Euglena gracilis 2018 ·Plant Molecular Biology ·Yiming Feng, (unknown), Jun Tanaka, Toki Taira, Takayuki Ohnuma, Finn L. Aachmann, Tamo Fukamizo	2
12	Enzymatic properties of a GH19 chitinase isolated from rice lacking a major loop structure involved in chitin binding 2017 ·Glycobiology ·Jun Tanaka, Tamo Fukamizo, Takayuki Ohnuma	11
13	SPECIAL ISSUE “ Roles of revegetation for preventing Sediment Disaster ” Effects of forest structure and topography on slope stability and mass wasting process 2015 ·Journal of the Japanese Society of Revegetation Technology ·Jun Tanaka, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), R Ohno	1
14	Synthesis and biological evaluation of novel (−)-cercosporamide derivatives as potent selective PPARγ modulators 2012 ·European Journal of Medicinal Chemistry ·Akihiro Furukawa, Tsuyoshi Arita, Takehiro Fukuzaki, Makoto Mori, Takeshi Honda, Susumu Satoh, Yumi Matsui, Kenji Wakabayashi, (unknown), Kouichi Nakamura, Kazushi Araki, Masanori Kuroha, Jun Tanaka, (unknown), Osamu Suzuki, Jun Ohsumi	13
15	Enhancement of Zidovudine Transfer to Molt-4 Cells, a Human T-Cell Model, by Dehydroepiandrosterone Sulfate 2011 ·Journal of Pharmaceutical Sciences ·Tomohiro Nishimura, Jun Tanaka, Masatoshi Tomi, (unknown), (unknown), Yoshimichi Sai, Emi Nakashima	5
16	2010 ·Journal of the Japanese Society of Revegetation Technology ·Jun Tanaka, (unknown), Tatsuhiro Ezawa, (unknown)	0
17	Discovery of potent and orally active tricyclic-based FBPase inhibitors 2010 ·Bioorganic & Medicinal Chemistry ·(unknown), Osamu Kanno, Takahiro Yamane, Jun Tanaka, (unknown), Akira Okuno, (unknown), Mizuki Takahashi, Takahide Nishi	9
18	A prodrug approach towards the development of tricyclic-based FBPase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Kazuhiko Tamaki, Jun Tanaka, Toshiyuki Takagi, (unknown), Akira Okuno, (unknown), Mizuki Takahashi, Takahide Nishi	9
19	Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats 2009 ·European Journal of Pharmacology ·(unknown), Akira Okuno, Jun Tanaka, Kanako Takahashi, (unknown), Shoichi Kanda, Junko Ogawa, (unknown), Toshihiko Fujiwara	24
20	Early Metabolic Disturbances in the Liver Following Unilateral Hepatic or Common Bile Duct Obstruction in Rabbits 1979 ·European Surgical Research ·Koichiro Ozawa, Jun Tanaka, (unknown), Kiminori Kimura, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact